Safety of nintedanib for treatment of fibrotic lung disease after allogeneic hematopoietic stem cell transplantation.

Kyle R Brownback; Lucas R Pitts; Sunil Abhyankar

首页> 外文期刊>Bone marrow transplantation >Safety of nintedanib for treatment of fibrotic lung disease after allogeneic hematopoietic stem cell transplantation.

【24h】

Safety of nintedanib for treatment of fibrotic lung disease after allogeneic hematopoietic stem cell transplantation.

机译：异种亚胺治疗同种异体造血干细胞移植治疗纤维化肺病的安全性。

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Bone marrow transplantation》 |2018年第9期|共3页
作者
Kyle R Brownback; Lucas R Pitts; Sunil Abhyankar;
展开▼
作者单位

Division of Pulmonary and Critical Care Medicine University of Kansas Medical Center Kansas City;

Division of Pulmonary and Critical Care Medicine University of Kansas Medical Center Kansas City;

Division of Hematologic Malignancies and Cellular Therapeutics University of Kansas Medical Center;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类治疗学;
关键词

相似文献

外文文献
中文文献
专利

1. Safety of nintedanib for treatment of fibrotic lung disease after allogeneic hematopoietic stem cell transplantation. [J] . Kyle R Brownback, Lucas R Pitts, Sunil Abhyankar Bone marrow transplantation . 2018,第9期

机译：异种亚胺治疗同种异体造血干细胞移植治疗纤维化肺病的安全性。
2. NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on Disease-Specific Methods and Strategies for Monitoring Relapse following Allogeneic Stem Cell Transplantation. Part I: Methods, acute leukemias, and myelodysplastic syndromes. [J] . Kroger N, Bacher U, Bader P, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2010,第9期

机译：NCI首届异基因造血干细胞移植后复发的生物学，预防和治疗国际研讨会：疾病特异性方法和策略委员会的报告，用于监测异基因干细胞移植后的复发。第一部分：方法，急性白血病和骨髓增生异常综合症。
3. NCI first international workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation: report from the committee on disease-specific methods and strategies for monitoring relapse following allogeneic stem cell transplantation. part II: chronic leukemias, myeloproliferative neoplasms, and lymphoid malignancies. [J] . Kroger N, Bacher U, Bader P, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2010,第10期

机译：NCI第一次国际研讨会，关于异基因造血干细胞移植后复发的生物学，预防和治疗：来自疾病特异性方法和策略委员会的报告，用于监测异基因干细胞移植后的复发。第二部分：慢性白血病，骨髓增生性肿瘤和淋巴样恶性肿瘤。
4. HEREDITARY METABOLIC DISEASES AND STEM CELL TRANSPLANTATION. [C] . G. Peter A. Smit International Symposium on Blood Transfusion . 2002

机译：遗传性代谢疾病和干细胞移植。
5. Symptoms, Cytokines, and Quality of Life of Patients with Chronic Graft-versus-Host Disease following Allogeneic Hematopoietic Stem Cell Transplantation. [D] . Kelly, Debra Lynch. 2014

机译：异基因造血干细胞移植后慢性移植物抗宿主病患者的症状，细胞因子和生活质量。
6. Diagnosis of acute graft-versus-host disease in the gastrointestinal tract of patients undergoing allogeneic hematopoietic stem cell transplantation. A descriptive and critical study of diagnostic tests [O] . Leticia Rocha Borges, Eduardo E. Vilela, Maria de Lourdes A. Ferrari, 2020

机译：诊断急性移植物与宿主疾病在经同种异体造血干细胞移植患者胃肠道中的疾病。对诊断测试的描述性和关键研究
7. NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Disease-Specific Methods and Strategies for Monitoring Relapse following Allogeneic Stem Cell Transplantation. Part I: Methods, Acute Leukemias, and Myelodysplastic Syndromes [O] . Kröger Nicolaus, Bacher Ulrike, Bader Peter, 2010

机译：NCI首届异基因造血干细胞移植后复发的生物学，预防和治疗国际研讨会：疾病特异性方法和策略委员会的报告，以监测异基因干细胞移植后的复发。第一部分：方法，急性白血病和骨髓增生异常综合症

Safety of nintedanib for treatment of fibrotic lung disease after allogeneic hematopoietic stem cell transplantation.

著录项

相似文献

相关主题

期刊订阅